Covered recipient · General Payments record
ABDUL GHANI
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$3,525.98
- Reported across 129 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $486.18 | 15 |
| Education | $11.29 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $160.85 | 6 |
| Lilly USA, LLC | $154.99 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $85.14 | 1 |
| Abbott Laboratories | $54.10 | 3 |
| Novo Nordisk AS | $42.39 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.01 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125203227 | CMS |
| Abbott Laboratories | $15.98 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125203229 | CMS |
| Abbott Laboratories | $23.11 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125203231 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $85.14 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118115383 | CMS |
| Corcept Therapeutics | $8.93 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117743688 | CMS |
| Corcept Therapeutics | $16.70 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117743744 | CMS |
| Corcept Therapeutics | $11.35 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117743780 | CMS |
| Corcept Therapeutics | $11.29 | 10/24/2024 | Education | Undisputed | 01/23/2026 | 1117743818 | CMS |
| Corcept Therapeutics | $102.18 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117743828 | CMS |
| Corcept Therapeutics | $10.40 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117743798 | CMS |
| Lilly USA, LLC | $25.17 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136003524 | CMS |
| Lilly USA, LLC | $22.07 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136003520 | CMS |
| Lilly USA, LLC | $6.45 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136004619 | CMS |
| Lilly USA, LLC | $101.30 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136003522 | CMS |
| Novo Nordisk Inc | $18.53 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096995033 | CMS |
| Novo Nordisk Inc | $23.86 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097498137 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.